Glenview Capital Management
Glenview Capital Management (GLENVIEW CAPITAL MANAGEMENT, LLC) reported 140 positions worth $5.63B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: GPN (9.5%). Biggest move: reduce CVS ($303.9M).
| # | Symbol | Company | Value ↓ | % Port. | Time Held | Shares | Est. Buy Price | Gain | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ▸ 1 | GPN | $580.3M | 9.47% | 6 Years | 7,105,453 | $100.07 | -10.2% | — | — | +10.0% | |
| ▸ 2 | THC | $523.3M | 8.54% | >10 Years | 2,047,843 | $97.49* | +199.0% | — | — | +14.1% | |
| ▸ 3 | AMZN | $372.6M | 6.08% | 3.8 Years | 1,495,483 | $217.93 | +18.3% | — | — | +3.5% | |
| ▸ 4 | META | $359.2M | 5.86% | 1.8 Years | 495,268 | $622.01 | +0.7% | — | — | -13.6% | |
| ▸ 5 | TMO | $299.9M | 4.89% | 1.5 Years | 444,245 | $471.52 | +46.6% | — | — | +2.4% | |
| ▸ 6 | TEVA | $299.6M | 4.89% | 3 Years | 7,566,877 | $35.70 | +19.2% | — | — | +7.5% | |
| ▸ 7 | A | $257.5M | 4.20% | 2 Q | 1,494,200 | $121.85 | +41.9% | — | — | +0.4% | |
| ▸ 8 | IWMPut | $255.7M notional | 4.17% | — | 920,000 | — | — | — | — | — | |
| ▸ 9 | AMD | $239.4M | 3.91% | 1 Year | 391,267 | $290.05 | +73.9% | — | — | -17.6% | |
| ▸ 10 | DHR | $234.3M | 3.82% | 1.5 Years | 1,057,645 | $183.81 | +25.1% | — | — | +3.8% |
Related managers
Five closest superinvestors by Jaccard overlap of tickers held in the latest quarter (computed nightly).
| Manager | Overlap | Shared holdings |
|---|---|---|
| D.E. Shaw & Co | 11.8% | BSX, EAT, BURL, CI, CVS, CVNA, DHR, DOCU +49 |
| Two Sigma Investments | 10.7% | BSX, CI, CVS, CDNS, CVNA, DHR, DOCU, HUM +52 |
| Alyeska Investment Group | 10.5% | BSX, EAT, BRKR, BURL, CVS, CVNA, DHR, HUM +28 |
| Bridgewater Associates (Ray Dalio) | 10.4% | BSX, CI, CVS, DHR, HUM, KLAC, LLY, MRVL +34 |
| Capital Research Global Investors | 10.4% | CI, CVS, CVNA, DHR, HUM, KLAC, LLY, MRVL +18 |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Glenview Capital Management hold as of Q3 2026?
Glenview Capital Management reported 140 positions worth $5.63B in its Q3 2026 13F filing. Largest positions: GPN (9.5%), THC (8.5%), AMZN (6.1%), META (5.9%) and TMO (4.9%).
What did Glenview Capital Management buy in Q3 2026?
New positions: SGRY, MRVL, ORCL, TXN and RRX (101 in all). Added to: ONTO, HUM, META, TEVA and BRKR (17 in all).
What did Glenview Capital Management sell in Q3 2026?
Reduced: CVS, VTRS, GPN, TMO and A (15 in all). Sold out entirely: DKS, FUN, STM, BKR and ELV (8 in all).
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.